Eyepoint Pharmaceuticals Inc (EYPT) Stock Decreases -3.25% This Week; Should You Buy?

Eyepoint Pharmaceuticals Inc (EYPT) stock is up 78.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives EYPT stock a score of 71 out of a possible 100.

That rank is influenced by a short-term technical score of 97. EYPT's rank also includes a long-term technical score of 41.

EYPT has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on EYPT!

See Full EYPT Report

What's Happening with EYPT Stock Today

Eyepoint Pharmaceuticals Inc (EYPT) stock is lower by -11.44% while the S&P 500 is lower by -0.26% as of 1:17 PM on Tuesday, Nov 21. EYPT is lower by -$0.81 from the previous closing price of $7.07 on volume of 413,190 shares. Over the past year the S&P 500 is up 14.83% while EYPT is up 78.35%. EYPT lost -$2.67 per share in the over the last 12 months. Click Here to get the full Stock Report for Eyepoint Pharmaceuticals Inc stock.